New wireless defibrillator approved
A newly approved wireless implantable cardioverter-defibrillator (ICD) may be alternative to a traditional ICD for people at risk for an infection of the wires placed into the heart or those with blocked or narrowed coronary veins. The new device, called a subcutaneous ICD (S-ICD), may also be useful for people who are at risk for a life-threatening arrhythmia, but who do not need the device to pace a slow or fast heart rhythm—capabilities the S-ICD does not have.
To continue reading this article, you must log in.
Source matters. Subscribe to HarvardHealthOnline+ FREE for 30 days for unlimited access to the site – where all content is reviewed by an HMS physician or faculty expert.
With HHO+ you get these exclusive benefits:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
SPECIAL OFFER! UNLOCK EXPERT ACCESS for 30 days FREE!
Already a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
